Full Length Research Paper
References
|
Arien-Zakay H, Lazarovici P, Nagler A (2010). Tissue regeneration potential in human umbilical cord blood. Best Practice Research in Clinical Haematology 23:291-303. |
|
|
Bakry S, Merhi ZO, Scalise TJ (2008). Depot-medroxyprogesterone Acetate: an update. Achives of Gynecology and Obsterics 278(1):1-12. |
|
|
Bashour T, Basha HS, Cheng TO (1980). Hypocalcaemic Cardiomyopathy. American College of Chest Physicians 78(4):663-665. |
|
|
Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL (2001). Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. The American Journal of Clinical Nutrition 74(4):549-554. |
|
|
Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A (2007). Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 369:1947-1954. |
|
|
Frangoul H, Wang L, Harrell FE, Manes B, Calder C, Domm J (2010). Unrelated umbilical cord blood transplantation in children with immune deficiency: results of a multicenter study. Bone Marrow Transplant 45:283-288. |
|
|
Ishihara M, Kirdani Y, Osawa Y, Sandberg AA (1976). The metabolic fate of medroxyprogesterone acetate in the baboon. The Journal of Steroid Biochemistry 7(1):65-70. |
|
|
Joseph BB (2014). Ibi; an examination of the Yoruba traditional existentialist conception of evil. Thought and Practice 6(2):55-73. |
|
|
Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K (2008). Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112:2979-2989. |
|
|
Thompson C (1995). Umbilical cords: turning garbage into clinical gold. Science 1995:805-806. |
|
|
Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C (2002). Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non-malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611-1618. |
|
|
Wore N, Buser A, Greinix HT, Hagglund H, Navarro W, Pulsipher MA, Nicoloso de Faveri G, Bengtsson M, Billen A, Espino G, Fechter M, Guidice V, Holig K, Kanamori H, Kodera Y, Leitner G, Netelenbos T, Niederwieser D, van Walraven SM, Rocha V, Torosian T, Vergueiro C, Weisdorf D, Yabe H, Halter JP (2015). Suitability criteria for adult related donors: a consensus statement from the world network for blood marrow transplantation committee on donor issues. Blood Marrow Transplant 21(12):2052-2060. |
|
|
Zhao Y, Mazzone T (2010). Human cord blood stem cells and the journey to a cure for type 1 diabetes. Autoimmunity Revolution 10:103-107. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
